|
|||||
|
|
Quality, innovation, and value for money: NICE and the British National Health Service |
|
| Authors: | Pearson Steven D Rawlins Michael D |
| Institution: | National Institute for Clinical Excellence, London, England (Drs Pearson and Rawlins); Department of Ambulatory Care and Prevention, Harvard Medical School and Harvard Pilgrim Health Care, Boston, Mass (Dr Pearson); and Wolfson Unit of Clinical Pharmacology, University of Newcastle, Newcastle upon Tyne, England (Dr Rawlins). |
| Abstract: | JAMA. 2005;294:2618-2622. The National Institute for Health and Clinical Excellence (NICE) was established as a part of the British National Health Service in 1999 to set standards for the adoption of new health care technologies and the management of specific conditions. In doing so it was required explicitly to take into account both clinical effectiveness and cost-effectiveness. This article describes how NICE has responded to the challenge and considers whether its experience of balancing quality, innovation, and value for money holds policy lessons for the United States. |
| Keywords: | |
| 本文献已被 PubMed 等数据库收录！ | |
| 点击此处可从《The Journal of the American Medical Association》浏览原始摘要信息 | |
| 点击此处可从《The Journal of the American Medical Association》下载免费的PDF全文 | |